Loading…
CIK 0001958125 • 7 13F filings • May 15, 2025 – Sep 2, 2026
Import this data to Google Sheets with:
=jivedata("catalio-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | $13.3M | 2.3%Prev: 2.5% | 98,514 SH | Decreased-63,627 SH |
| ADAPTIVE BIOTECHNOLOGIES COR | COM | $13.3M | 2.4%Prev: 2.4% | 821,195 SH | Increased-63,695 SH |
| ADMA BIOLOGICS INC | COM | $10.3M | 1.8%Prev: 1.9% | 564,461 SH | Increased-120,047 SH |
| ARCELLX INC | COMMON STOCK | $10.2M | 1.8% | 156,109 SH | New |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $25.4M | 4.5%Prev: 5.3% | 119,265 SH | Decreased-25,689 SH |
| ATAI BECKLEY NV | SHS | $805K | 0.1% | 196,858 SH | New |
| BILLIONTOONE INC | CL A | $2.1M | 0.4% | 25,505 SH | New |
| BOSTON SCIENTIFIC CORP | COM | $34.4M | 6.1%Prev: 4.7% | 360,428 SH | Increased+97,456 SH |
| BRIDGEBIO PHARMA INC | COM | $31.4M | 5.6%Prev: 6.0% | 410,700 SH | Decreased-212,029 SH |
| BRISTOL-MYERS SQUIBB CO | COM | $34.9M | 6.2% | 647,899 SH | New |
| CYTOKINETICS INC | COM NEW | $16.4M | 2.9%Prev: 4.6% | 258,381 SH | Decreased-193,200 SH |
| DIANTHUS THERAPEUTICS INC | COM | $26.9M | 4.8%Prev: 4.9% | 653,572 SH | Increased-14,043 SH |
| DISC MEDICINE INC | COM | $8.8M | 1.5%Prev: 2.6% | 110,427 SH | Decreased-106,100 SH |
| DYNE THERAPEUTICS INC | COM | $10.2M | 1.8% | 519,715 SH | New |
| EDWARDS LIFESCIENCES CORP | COM | $15.9M | 2.8% | 187,048 SH | New |
| ELEDON PHARMACEUTICALS INC | COM | $1.9M | 0.3%Prev: 0.5% | 1,259,820 SH | Decreased+198,688 SH |
| ELI LILLY & CO | COM | $27.9M | 4.9%Prev: 8.1% | 25,923 SH | Decreased-31,453 SH |
| FRACTYL HEALTH INC | COM | $12.1M | 2.1%Prev: 1.5% | 5,491,866 SH | Increased+277,630 SH |
| FULCRUM THERAPEUTICS INC | COM | $2.3M | 0.4% | 201,301 SH | New |
| GILEAD SCIENCES INC | COM | $35.5M | 6.3% | 289,312 SH | New |
| GRAIL INC | COM | $2.6M | 0.5%Prev: 1.5% | 30,313 SH | Decreased-107,615 SH |
| HEARTFLOW INC | COM | $3.3M | 0.6% | 113,857 SH | New |
| HYPERFINE INC | COM CL A | $1.3M | 0.2%Prev: 0.2% | 1,320,041 SH | Increased+635,500 SH |
| INTUITIVE SURGICAL INC | COM NEW | $15.4M | 2.7%Prev: 5.9% | 27,209 SH | Decreased-44,134 SH |
| JOHNSON & JOHNSON | COM | $25.0M | 4.4% | 120,840 SH | New |
| KARYOPHARM THERAPEUTICS INC | COM NEW | $1.1M | 0.2%Prev: 0.2% | 142,984 SH | Increased |
| METAGENOMI INC | COM | $857K | 0.2%Prev: 0.2% | 528,993 SH | Decreased |
| MINERALYS THERAPEUTICS INC | COM | $12.0M | 2.1% | 331,849 SH | New |
| NATERA INC | COM | $14.3M | 2.5%Prev: 4.4% | 62,273 SH | Decreased-86,096 SH |
| OCULAR THERAPEUTIX INC | COM | $8.7M | 1.5% | 714,501 SH | New |
| OLEMA PHARMACEUTICALS INC | COM | $6.7M | 1.2% | 267,058 SH | New |
| OUTSET MED INC | COM NEW | $439K | 0.1%Prev: 0.3% | 118,279 SH | Decreased |
| PALVELLA THERAPEUTICS INC NE | COM | $1.1M | 0.2%Prev: 0.1% | 10,452 SH | Increased-1,558 SH |
| PHATHOM PHARMACEUTICALS INC | COM | $11.6M | 2.0%Prev: 2.5% | 698,996 SH | Decreased-429,525 SH |
| PROTARA THERAPEUTICS INC | COM STK | $7.7M | 1.4%Prev: 1.2% | 1,446,254 SH | Increased-54,539 SH |
| REGENERON PHARMACEUTICALS | COM | $23.0M | 4.1%Prev: 3.7% | 29,797 SH | Increased-5,547 SH |
| SENSEI BIOTHERAPEUTICS INC | COM NEW | $157K | 0.0%Prev: 0.0% | 14,718 SH | Increased |
| SEPTERNA INC | COM | $8.2M | 1.5%Prev: 1.0% | 294,360 SH | Increased |
| SOLENO THERAPEUTICS INC | COM | $16.7M | 2.9%Prev: 5.2% | 360,340 SH | Decreased-57,905 SH |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $17.6M | 3.1%Prev: 3.4% | 252,901 SH | Decreased-398,909 SH |
| SUPERNUS PHARMACEUTICALS INC | COM | $12.8M | 2.3%Prev: 2.5% | 257,465 SH | Decreased-29,625 SH |
| SYNDAX PHARMACEUTICALS INC | COM | $25.1M | 4.4%Prev: 4.6% | 1,196,807 SH | Increased-417,910 SH |
| TERNS PHARMACEUTICALS INC | COM | $5.5M | 1.0% | 136,958 SH | New |
| ULTRAGENYX PHARMACEUTICAL IN | COM | $3.7M | 0.7%Prev: 1.6% | 162,550 SH | Decreased-128,712 SH |
| UNIQURE NV | SHS | $6.9M | 1.2%Prev: 3.1% | 288,345 SH | Decreased+5,405 SH |
| 13F-HR |
| 0001958125-26-000005 |
| $532.1M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001958125-25-000007 | $476.9M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001958125-26-000003 | $478.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001958125-25-000004 | $411.1M | View |